External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Yang, Bi Ling ^a,b   Wu, Wen Chieh ^c,d   Fang, Kuan Chieh ^a   Wang, Yuan Chen ^a,d   Huo, Teh Ia ^a,d   Huang, Yi Hsiang ^a,d   Yang, Hwai I ^e   Su, Chien Wei ^a,d   Lin, Han Chieh ^a,d   Lee, Fa Yauh ^a,d   Wu, Jaw Ching ^a,d   Lee, Shou Dong ^b,d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; TRIACYLGLYCEROL;

ADULT; ALGORITHM; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIGESTIVE TRACT PARAMETERS; ECHOGRAPHY; FATTY LIVER; FATTY LIVER INDEX; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT IDENTIFICATION; RECEIVER OPERATING CHARACTERISTIC; TAIWAN; TAIWANESE; TRIACYLGLYCEROL BLOOD LEVEL; VALIDATION PROCESS; WAIST CIRCUMFERENCE; AGED; CLINICAL TRIAL; DIAGNOSTIC IMAGING; LIVER; MIDDLE AGED; MULTICENTER STUDY;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; TAIWAN; ULTRASONOGRAPHY;

EID: 84924940496     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120443     Document Type: Article

References (39)

1. Armstrong MJ, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 2014; 59: 1174-1197. doi: 10.1002/hep.26717 PMID: 24002776
2. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of nonalcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-285. doi: 10.1111/j.1365-2036.2011.04724.x PMID: 21623852
3. Nascimbeni F, Pais R, Bellentani S, Day CP, Ratziu V, Loria P, et al. From NAFLD in clinical practice to answers from guidelines. J Hepatol 2013; 59: 859-871. doi: 10.1016/j.jhep.2013.05.044 PMID: 23751754
4. Loomba R, Abraham M, Unalp A, Wilson L, Lavine J, Doo E, et al. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 2012; 56: 943-951. doi: 10.1002/hep.25772 PMID: 22505194
5. Lee JY, Kim KM, Lee SG, Yu E, Lim YS, Lee HC, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 2007; 47: 239-244. PMID: 17400323
6. Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 2009; 50: 204-210. doi: 10.1016/j.jhep.2008.10.010 PMID: 19014878
7. Wong VW. Nonalcoholic fatty liver disease in Asia: a story of growth. J Gastroenterol Hepatol 2013; 28: 18-23. doi: 10.1111/jgh.12259 PMID: 24251698
8. Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011; 9: 524-530. doi: 10.1016/j.cgh.2011.03.020 PMID: 21440669
9. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142: 1592-1609. doi: 10.1053/j.gastro.2012.04.001 PMID: 22656328
10. Angulo P, Bugianesi E, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Barrera F, et al. Simple non-invasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2013; 145: 782-789. doi: 10.1053/j.gastro.2013.06.057 PMID: 23860502
11. Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011; 141: 1249-1253. doi: 10.1053/j.gastro.2011.06.061 PMID: 21726509
12. Welzel TM, Graubard BI, Quraishi S, Zeuzem S, Davila JA, El-Serag HB, et al. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol 2013; 108: 1314-1321. doi: 10.1038/ajg.2013.160 PMID: 23752878
13. Hyysalo J, Mannisto VT, Zhou Y, Arola J, Karja V, Leivonen M, et al. A population-based study on the prevalence of NASH using scores validated against liver histology. J Hepatol 2014; 60: 839-846. doi: 10.1016/j.jhep.2013.12.009 PMID: 24333862
14. Pais R, Charlotte F, Fedchuk L, Bedossa P, Lebray P, Poynard T, et al. A systematic review of followup biopsies reveals disease progression in patients with non-alcoholic fatty liver. J Hepatol 2013; 59: 550-556. doi: 10.1016/j.jhep.2013.04.027 PMID: 23665288
15. Wong VW, Chu WC, Wong GL, Chan RS, Chim AM, Ong A, et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 2012; 61: 409-415. doi: 10.1136/gutjnl-2011-300342 PMID: 21846782
16. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6: 33. PMID: 17081293
17. Koehler EM, Schouten JN, Hansen BE, Hofman A, Stricker BH, Janssen HL, et al. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol 2013; 11: 1201-1204. doi: 10.1016/j.cgh.2012.12.031 PMID: 23353640
18. Bedogni G, Kahn HS, Bellentani S, Tiribelli C. A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol 2010; 10: 98. doi: 10.1186/1471-230X-10-98 PMID: 20738844
19. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-1725. PMID: 12404245
20. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011; 54: 1082-1090. doi: 10.1002/hep.24452 PMID: 21618575
21. Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 2009; 51: 1061-1067. doi: 10.1016/j.jhep.2009.09.001 PMID: 19846234
22. Wu WC, Wu CY, Wang YJ, Hung HH, Yang HI, Kao WY, et al. Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects. Aliment Pharmacol Ther 2012; 36: 560-568. doi: 10.1111/j.1365-2036.2012.05224.x PMID: 22817613
23. Koehler EM, Schouten JN, Hansen BE, van Rooij FJ, Hofman A, Stricker BH, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. J Hepatol 2012; 57: 1305-1311. doi: 10.1016/j.jhep.2012.07.028 PMID: 22871499
24. Wong RJ, Ahmed A. Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations. World J Hepatol 2014; 6: 263-273. doi: 10.4254/wjh.v6.i5.263 PMID: 24868320
25. Palaniappan LP, Wong EC, Shin JJ, Fortmann SP, Lauderdale DS. Asian Americans have greater prevalence of metabolic syndrome despite lower body mass index. Int J Obes (Lond) 2011; 35: 393-400. doi: 10.1038/ijo.2010.152 PMID: 20680014
26. Treeprasertsuk S, Leverage S, Adams LA, Lindor KD, St Sauver J, Angulo P. The Framingham risk score and heart disease in nonalcoholic fatty liver disease. Liver Int 2012; 32: 945-950. doi: 10.1111/j.1478-3231.2011.02753.x PMID: 22299674
27. Paradis V, Zalinski S, Chelbi E, Guedj N, Degos F, Vilgrain V, et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 2009; 49: 851-859. doi: 10.1002/hep.22734 PMID: 19115377
28. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363: 1341-1350. doi: 10.1056/NEJMra0912063 PMID: 20879883
29. Kim D, Choi SY, Park EH, Lee W, Kang JH, et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 2012; 56: 605-613. doi: 10.1002/hep.25593 PMID: 22271511
30. Gastaldelli A, Kozakova M, Hojlund K, Flyvbjerg A, Favuzzi A, Kim W, et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 2009; 49: 1537-1544. doi: 10.1002/hep.22845 PMID: 19291789
31. th year of follow-up. Hepatology 2011; 54: 145-152. doi: 10.1002/hep.24356 PMID: 21488080
32. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645. doi: 10.1161/CIRCULATIONAHA.109.192644 PMID: 19805654
33. Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 2010; 11: 11-18. doi: 10.1111/j.1467-789X.2009.00623.x PMID: 19656312
34. Ayonrinde OT, Olynyk JK, Beilin LJ, Mori TA, Pennell CE, de Klerk N, et al. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology 2011; 53: 800-809. doi: 10.1002/hep.24097 PMID: 21374659
35. Han SI, Komatsu Y, Murayama A, Steffensen KR, Nakagawa Y, Nakajima Y, et al. Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice. Hepatology 2014; 59: 1791-1802. doi: 10.1002/hep.26951 PMID: 24277692
36. Yang JD, Abdelmalek MF, Pang H, Guy CD, Smith AD, Diehl AM, et al. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology 2014; 59: 1406-1414. doi: 10.1002/hep.26761 PMID: 24123276
37. Cheng YL, Wang YJ, Kao WY, Chen PH, Huo TI, Huang YH, et al. Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up. PLoS One 2013; 8: e72049. doi: 10.1371/journal.pone.0072049 PMID: 23991037
38. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, et al. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. J Gastroenterol Hepatol 2007; 22: 1482-1489. PMID: 17716352
39. Lin CY, Chen KH, Chang HY, Tseng FY, Chen CY. The relationship between the pattern of alcohol consumption and healthcare utilization in Taiwan. Taiwan J Public Health 2014; 33: 197-208.